FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David McKenna

Research Profile

Anatomy

Procedures

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Hans Klingemann; Raymond L Comenzo; Elliott Cutler; Marvin Duque; Carrie Grodman; Diane Kadidlo; Tarun Kewalramani; Andreas K Klein; Kenneth B Miller; Kellie A Sprague; Richard A Van Etten; Neng Yu; David H McKenna
Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions.
Scott A Koepsell; Jeffrey S Miller; David H McKenna
Natural killer cells: a review of manufacturing and clinical utility.
Scott A Koepsell; Jeffrey McCullough; Susan Fautsch; Diane Kadidlo; Hans Klingemann; Jeffrey S Miller; John E Wagner; David H McKenna
Successful "in-flight" activation of natural killer cells during long-distance shipping.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David McKenna (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hans Klingemann; Raymond L Comenzo; Elliott Cutler; Marvin Duque; Carrie Grodman; Diane Kadidlo; Tarun Kewalramani; Andreas K Klein; Kenneth B Miller; Kellie A Sprague; Richard A Van Etten; Neng Yu; David H McKenna
Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions.
Transfusion 2013;53(2):412-8; quiz 411.
2013: Scott A Koepsell; Jeffrey S Miller; David H McKenna
Natural killer cells: a review of manufacturing and clinical utility.
Transfusion 2013;53(2):404-10.
2013: Scott A Koepsell; Jeffrey McCullough; Susan Fautsch; Diane Kadidlo; Hans Klingemann; Jeffrey S Miller; John E Wagner; David H McKenna
Successful "in-flight" activation of natural killer cells during long-distance shipping.
Transfusion 2013;53(2):398-403.
2012: Sara Richman; Robert D Simari; Doris A Taylor; Jay H Traverse; James T Willerson; David Zhao; Saif Anwaruddin; Jeannette Bloom; Christopher R Cogle; Diann Fisk; Adrian P Gee; Timothy D Henry; Jane Reese Koç; David H McKenna; Lemuel A Moyé; Carl J Pepine; Karen Prater; Sonia I Skarlatos
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study.
Transfusion 2012;52(10):2225-33.
2012: P Ramirez; Michael verneris; John E Wagner; Daniel J Weisdorf; Todd E DeFor; Philip B McGlave; David H McKenna; Jeffrey S Miller; Bruce R Blazar; Claudio G Brunstein
Factors predicting single-unit predominance after double umbilical cord blood transplantation.
Bone marrow transplantation 2012;47(6):799-803.
2012: David H McKenna; Sarah Cooley; Diane Kadidlo; Jeffrey S Miller
Clinical production and therapeutic applications of alloreactive natural killer cells.
Methods in molecular biology (Clifton, N.J.) 2012;882():491-507.
2011: Maria Nawrot; Deanna Nielsen; Helen Belfield; Elke Grassman; David H McKenna; John McMannis; Darin Sumstad; Zbigniew M Szczepiorkowski; Toni Temples; Bert Wognum; Ning Yuan; Jo Anna Reems
Interlaboratory assessment of a novel colony-forming unit assay: a multicenter study by the cellular team of Biomedical Excellence for Safer Transfusion (BEST) collaborative.
Transfusion 2011;51(9):2001-5.
2011: Keli L Hippen; Sarah C Merkel; Dawn K Schirm; Christine M Sieben; Darin Sumstad; Diane M Kadidlo; David H McKenna; Jonathan Bromberg; Bruce L Levine; James L Riley; Carl H June; Phillip Scheinberg; Daniel C Douek; Jeffrey S Miller; John E Wagner; Bruce R Blazar
Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity.
Science translational medicine 2011;3(83):83ra41.
2011: Claudio G Brunstein; Jeffrey S Miller; Qing Cao; David H McKenna; Keli L Hippen; Julie Curtsinger; Todd E DeFor; Bruce L Levine; Carl H June; Pablo Rubinstein; Philip B McGlave; Bruce R Blazar; John E Wagner
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.
Blood 2011;117(3):1061-70.
2011: Michael J Berger; Sharon R Minnerath; Stacey L Sprague; Barbara M Tigges; Sheryl D Adams; David H McKenna
Gene expression changes with differentiation of cord blood stem cells to respiratory epithelial cells: a preliminary observation.
Stem cell research & therapy 2011;2(2):19.
2010: Veronika Bachanova; Linda J Burns; David H McKenna; Julie Curtsinger; Angela Panoskaltsis-Mortari; Bruce R Lindgren; Sarah Cooley; Daniel Weisdorf; Jeffrey S Miller
Allogeneic natural killer cells for refractory lymphoma.
Cancer immunology, immunotherapy : CII 2010;59(11):1739-44.
2010: Jay H Traverse; David H McKenna; Karen Harvey; Beth C Jorgenso; Rachel E Olson; Nancy Bostrom; Diane Kadidlo; John R Lesser; Vikrant Jagadeesan; Ross Garberich; Timothy D Henry
Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction.
American heart journal 2010;160(3):428-34.
2010: David H McKenna; Sheryl Adams; Darin Sumstad; Therese Sumstad; Diane Kadidlo; Adrian P Gee; April Durett; Debe Griffin; Albert Donnenberg; David Amrani; Deborah Livingston; Robert Lindblad; Deborah Wood; David Styers
CD34(+) cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicine.
Cytotherapy 2010;12(2):170-7.
2010: Jay H Traverse; Timothy D Henry; Douglas E Vaughan; Stephen G Ellis; Carl J Pepine; James T Willerson; David X M Zhao; Lara M Simpson; Marc S Penn; Barry J Byrne; Emerson C Perin; Adrian P Gee; Antonis K Hatzopoulos; David H McKenna; John R Forder; Doris A Taylor; Christopher R Cogle; Sarah Baraniuk; Rachel E Olson; Beth C Jorgenson; Shelly L Sayre; Rachel W Vojvodic; David J Gordon; Sonia I Skarlatos; Lemuel A Moyè; Robert D Simari
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2010;37(4):412-20.
2009: Michael verneris; Claudio G Brunstein; Juliet N Barker; Margaret L MacMillan; Todd E DeFor; David H McKenna; Michael J Burke; Bruce R Blazar; Jeffrey S Miller; Philip B McGlave; Daniel J Weisdorf; John E Wagner
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.
Blood 2009;114(19):4293-9.
2009: Jay H Traverse; Timothy D Henry; Douglas E Vaughan; Douglas E Vaughn; Stephen G Ellis; Carl J Pepine; James T Willerson; David X M Zhao; Linda B Piller; Marc S Penn; Barry J Byrne; Emerson C Perin; Adrian P Gee; Antonis K Hatzopoulos; David H McKenna; John R Forder; Doris A Taylor; Christopher R Cogle; Rachel E Olson; Beth C Jorgenson; Shelly L Sayre; Rachel W Vojvodic; David J Gordon; Sonia I Skarlatos; Lemuel A Moye'; Robert D Simari
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.
American heart journal 2009;158(3):356-63.
2008: Bharat Thyagarajan; Michael Berger; Darin Sumstad; David H McKenna
Loss of integrity of umbilical cord blood unit freezing bags: description and consequences.
Transfusion 2008;48(6):1138-42.
2007: David H McKenna; Darin Sumstad; Nancy Bostrom; Diane Kadidlo; Susan Fautsch; Sarah McNearney; Rose Dewaard; Philip B McGlave; Daniel J Weisdorf; John E Wagner; Jeffrey McCullough; Jeffrey S Miller
Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience.
Transfusion 2007;47(3):520-8.
2006: Mark A Klein; Diane Kadidlo; Jeffrey McCullough; David H McKenna; Linda J Burns
Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(11):1142-9.
2006: M J Berger; S D Adams; B M Tigges; S L Sprague; X-J Wang; D P Collins; David H McKenna
Differentiation of umbilical cord blood-derived multilineage progenitor cells into respiratory epithelial cells.
Cytotherapy 2006;8(5):480-7.
2005: Vincent Laroche; David H McKenna; Gary Moroff; Therese Schierman; Diane Kadidlo; Jeffrey McCullough
Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples.
Transfusion 2005;45(12):1909-16.
2005: David H McKenna; Diane Kadidlo; Jeffrey S Miller; Paul J Orchard; John E Wagner; Jeffrey McCullough
The Minnesota Molecular and Cellular Therapeutics Facility: a state-of-the-art biotherapeutics engineering laboratory.
Transfusion medicine reviews 2005;19(3):217-28.
2002: David H McKenna; Ted Eastlund; Miriam Segall; Harriet Noreen; Soon Park
HLA alloimmunization in patients requiring ventricular assist device support.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2002;21(11):1218-24.